Di-podocarpanoid hugonone B - Compound Card

Di-podocarpanoid hugonone B

Select a section from the left sidebar

Di-podocarpanoid hugonone B

Structure
Zoomed Structure
  • Family: Plantae - Liliaceae
  • Kingdom: Plantae
  • Class: Terpenoid
Canonical Smiles O=C1[C@@H]2C3=C([C@@H](C1(C)O)[C@H]1[C@@]42CC[C@H]2[C@@](C4=CC(=O)[C@@]1(C)O)(C)CC[C@@H](C2(C)C)O)CC[C@H]1[C@@]3(C)CCC(=O)C1(C)C
InChI InChI=1S/C36H50O6/c1-30(2)19-10-9-18-25(33(19,6)15-13-23(30)38)27-29(40)35(8,42)26(18)28-34(7,41)24(39)17-21-32(5)14-12-22(37)31(3,4)20(32)11-16-36(21,27)28/h17,19-20,22,26-28,37,41-42H,9-16H2,1-8H3/t19-,20-,22+,26-,27+,28-,32-,33-,34-,35?,36+/m1/s1
InChIKey PQWZTIFQLLOKAH-VRWXKVQMSA-N
Formula C36H50O6
HBA 6
HBD 3
MW 578.79
Rotatable Bonds 0
TPSA 111.9
LogP 5.13
Number Rings 8
Number Aromatic Rings 0
Heavy Atom Count 42
Formal Charge 0
Fraction CSP3 0.81
Exact Mass 578.36
Number of Lipinski Rule Violations 2
# Species Family Kingdom NCBI Taxonomy ID
1 Hugonia busseana Liliaceae Plantae 586373

Showing of synonyms

  • Baraza LD, Joseph CC, et al. (2007). A new cytotoxic and larvicidal himachalenoid, rosanoids and other constituents of Hugonia busseana.. Natural Product Research,2007,21(11),1027-1031. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCCC(CC2)C1C(C234)=CC(=O)CC4C5C6=C(C3C(=O)C5)C7C(CC6)CC(=O)CC7

Level: 0

Mol. Weight: 578.79 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.97
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.6
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
1.66

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
1.86
Plasma Protein Binding
93.18
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
7.6
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-1.29
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.45
Liver Injury II
Toxic
hERG Blockers
Toxic
Daphnia Maga
7.21
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
-6500.3
Rat (Acute)
3.1
Rat (Chronic Oral)
1.91
Fathead Minnow
19.35
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
397.75
Hydration Free Energy
-2.84
Log(D) at pH=7.4
4.57
Log(P)
4.58
Log S
-5.42
Log(Vapor Pressure)
-11.12
Melting Point
308.5
pKa Acid
5.99
pKa Basic
3.49

No predicted protein targets found for this compound.

Download SDF